000			02658nam a22003617a 4500
003			ZW-GwMSU
005			20201022105557.0
008			201022b ||||| |||| 00| 0 eng d
020			_a9781455728657 (hbk.)
040			_arda _beng _cMSU _erda
050	0	0	_aRC261.N533
100	1		_aNiederhuber, John E. _eauthor, MD. _eExecutive Vice President, Inova Health System. _eCEO and Director, Inova Comprehensive Cancer and Research Institute. _eCEO, Inova Translational Medicine Institute, Falls Church, Virginia _eProfessor, Oncology and Surgery, The John Hopkins University School of Medicine. _eDeputy Director, John Hopkins Clinical Research Network, Baltimore, Maryland,
240	1	0	_aClinical oncology
245	1	0	_aAbeloff's clinical oncology / _cby John E. Niederhuber, James O. Armitage, James H. Doroshow, Michael B. Kastan and Joel E. Tepper.
250			_aFifth Edition.
264		1	_aPhiladelphia, Pennsylvania : _bElsevier, _c2014
264		4	_c©2014
300			_axxxiv, 2186 pages _bill. (some col.) ; _c28 cm.
336			_atext _2rdacontent
336			_astill image _2rdacontent
337			_aunmediated _2rdamedia
338			_avolume _2rdacarrier
504			_aIncludes bibliographical referenecs and index.
505	0		_apt. I. Science of clinical oncology -- sect. A. Biology and cancer -- sect. B. Genesis of cancer -- sect. C. Diagnosing cancer -- sect. D. Preventing and treating cancer -- pt. II. Problems common to cancer and its therapy -- sect. A. Hematologic problems and infections -- sect. B. Metabolic and paraneoplastic syndromes -- sect. C. Local effects of cancer and its metastasis -- sect. D. Complications of therapy -- sect. E. Special populations -- pt. III. Specific malignancies.
520			_aCaptures the scientific discoveries and their implications for cancer diagnosis and management of cancer in the accessible manner possible.
650		0	_aOncology.
650		0	_aCancer.
700	1		_aArmitage, James O., _d1946- _eauthor, MD. _eJoe Shapiro Professor of Medicine, University of Nebraska Medical Center, Omaha, Nebraska.
700	1		_aDoroshow, James H., _eauthor, MD. _eBethesda, Maryland.
700	1		_aKastan, M. B. _q(Michael B.), _eauthor, MD, PhD. _eExecutive Director, Duke Cancer Institute, William W. Shingleton Professor, Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina.
700	1		_aTepper, Joel E., _eauthor, MD. _eHector MacLean Distinguished Professor of Cancer research, Department of Radiation Oncology, UNC Lineberger Comprehensive Cancer Center. University of North Carolina School of Medicine, Chapel Hill,North Carolina.
942			_2lcc _cB
999			_c155570 _d155570